Two promising ANZCHOG-sponsored clinical trials awarded funding by Australian Government
The Australian Government has awarded ANZCHOG more than $2.5 million in support of two international paediatric cancer clinical trials; BEACON2 and VICTORY.
ANZCHOG 2024 ASM
This year’s ASM will run from 1 – 3 August and submissions for abstracts are now open. It’s all happening in Adelaide (Tarntanya) this year, with the theme, “Sparking hope through cutting edge technologies and collaborative care. Tangka parranthi.”.
REGO-EWING trial opens in third Australian state
The ANZCHOG sponsored, REGO-EWING trial has recently opened at Monash Children’s Hospital, having opened earlier this year at Perth Children’s Hospital and Queensland Children’s Hospital.
A call to federal government for equitable access to a promising high-risk neuroblastoma treatment
Neuroblastoma Australia, together with ANZCHOG and Australian paediatric oncologists, has written to request the federal government urgently consider providing interim funding for Australian children with high-risk neuroblastoma to access eflornithine.
Celebrating Doctors’ Day
30 March marks Doctors’ Day, an international day to recognise the important contribution doctors make in our communities.
Review of the Australian Brain Cancer Mission
We're proud to share the fantastic commendation ANZCHOG received in the review of the Australian Brain Cancer Mission.
ACCELERATE 2024 Paediatric Oncology Conference
Last week, ANZCHOG Chair, Prof. Nick Gottardo, CEO, Robyn Strong and lived-experience advocate, Lucy Jones, had the wonderful opportunity to attend the ACCELERATE conference in Brussels.
An important day for childhood brain cancer research!
ANZCHOG welcomes last week’s announcement from Health Minister Mark Butler MP, committing up to $20 million for clinical trials and work to find treatments for brain cancers in Australian children.
Partners in Paediatric Cancer Trials: Carrie’s Beanies 4 Brain Cancer
We chat to Carrie’s Beanies 4 Brain Cancer to find out more about how and why they support ANZCHOG’s clinical cancer trials.